CSPG4 is highly expressed in various refractory malignant tumors, such as triple-negative breast cancer, glioblastoma, mesothelioma, and melanoma (Wang et al., 2010; Svendsen et al., 2011; Rivera et al., 2012). The gene discussed is CSPG4; the disease is melanoma.